Clinical Trials
All Clinical Trials - Page 28 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03444025Phase 2Unknown
Neoadjuvant Goserelin for Triple Negative Breast Cancer
Gonadorelin
- NCT03331289Phase 4Completed
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
Exenatide
- NCT03492580N/ACompleted
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Liraglutide
- NCT03419624Phase 3Terminated
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
Exenatide
- NCT03226821Phase 4Terminated
Body Composition and Adipose Tissue in HIV
Tesamorelin
- NCT03768518N/AUnknown
GLP-1 Receptor Expression in CHI
Exenatide
- NCT06611904N/AActive Not Recruiting
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
Dulaglutide
- NCT03225209Phase 2Completed
Medically Reproducing Bariatric Surgery
Liraglutide
- NCT02736435Phase 3Withdrawn
Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
Gonadorelin
- NCT03388619Phase 1Completed
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
Gonadorelin
- NCT03431844N/ACompleted
Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation
Humanin
- NCT03466021Phase 4Completed
Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
Liraglutide
- NCT03383068Phase 4Unknown
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
Exenatide
- NCT03447132Phase 3Completed
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Gonadorelin
- NCT03373708Phase 2/Phase 3Unknown
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer
Gonadorelin
- NCT03350191Phase 1Completed
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
Exenatide
- NCT03375463Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Participants
Tirzepatide
- NCT03307720N/AUnknown
Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)
Gonadorelin
- NCT03306498N/AUnknown
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy
KPV
- NCT02981069Phase 4Completed
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
Exenatide
- NCT03374956Phase 3Completed
Individualized Obesity Pharmacotherapy
Liraglutide
- NCT03363906Phase 1Completed
A Study of Dulaglutide in Healthy Participants
Dulaglutide
- NCT02972060Phase 2Active Not Recruiting
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
Gonadorelin
- NCT03291821N/ACompleted
DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore
Gonadorelin
- NCT03336983Phase 2Completed
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients
Gonadorelin
- NCT03421639Phase 4Unknown
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
Gonadorelin
- NCT04839237Phase 2Withdrawn
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
Liraglutide
- NCT03239119Phase 3Unknown
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Exenatide
- NCT03523273Phase 2Completed
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
Liraglutide
- NCT03036800Phase 4Completed
Saxenda in Obesity Services (STRIVE Study)
Liraglutide
- NCT03352869Phase 4Completed
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
Exenatide
- NCT03287076Phase 2Unknown
Trial of EXenatide in Acute Ischaemic Stroke
Exenatide
- NCT02956447Phase 2Completed
Administration of Kisspeptin in Patients With Hyperprolactinemia
Kisspeptin
- NCT03444142Phase 4Unknown
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
Dulaglutide
- NCT03322631Phase 1Completed
A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
Tirzepatide
- NCT03878706N/ARecruiting
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
MOTS-c
- NCT03315780Phase 4Completed
A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
Dulaglutide
- NCT03325387Phase 1Completed
A Study of Multiple Doses of LY3305677 in Healthy Participants
Mazdutide
- NCT03449654Phase 4Completed
Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
Liraglutide
- NCT03448744Phase 4Unknown
Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients
Thymosin-Alpha-1
- NCT03371862Phase 2Withdrawn
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
Liraglutide
- NCT03311724Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Tirzepatide
- NCT03323749Phase 3Terminated
A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension
Elamipretide
- NCT03272477Phase 2Completed
Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
Gonadorelin
- NCT03279731Phase 3Terminated
Binge Eating Liraglutide Intervention
Liraglutide
- NCT03292185Phase 1Completed
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
Liraglutide
- NCT03936049N/ACompleted
Replication of the LEADER Diabetes Trial in Healthcare Claims
Liraglutide
- NCT03361098Phase 4Completed
DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
Exenatide
- NCT03160261Phase 4Completed
Effect of Exenatide on Cortisol Secretion
Exenatide
- NCT03056755Phase 2Completed
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
Gonadorelin